Immunogenicity and tolerability of booster doses of AERAS 402 after priming with BCG.
Phase of Trial: Phase I
Latest Information Update: 14 Apr 2010
At a glance
- Drugs BCG vaccine; Tuberculosis vaccine
- Indications Tuberculosis
- Focus Adverse reactions; Pharmacodynamics
- Sponsors Crucell
- 14 Apr 2010 Status changed from not yet recruiting to recruiting, based on results in a Crucell media release.
- 28 Dec 2007 New trial record.